Influence of therapy on the antioxidant status in patients with melanoma

Journal of Clinical Pharmacy and Therapeutics

Volumn 33, Issue 2, 2008, Pages 179-185

  Gadjeva, V ^a   Dimov, A ^b   Georgieva, N ^c  

^a TRAKIA UNIVERSITY   (Bulgaria)

^b Regional Oncological Centre   (Bulgaria)

^c TRAKIA UNIVERSITY   (Bulgaria)

Author keywords

Catalase; CCNU; DTIC; Lipid peroxidation; Melanoma diseases; Superoxide dismutase

Indexed keywords

CATALASE; DACARBAZINE; LOMUSTINE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE COURSE; DRUG BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; MELANOMA; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; OXIDATIVE STRESS; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIOXIDANTS; CATALASE; DACARBAZINE; FEMALE; HUMANS; LIPID PEROXIDATION; LOMUSTINE; MALE; MALONDIALDEHYDE; MELANOMA; MIDDLE AGED; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE;

EID: 40349114370     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2008.00909.x     Document Type: Article

References (29)

1. Freeman BA, Crapo JD (1982) Biology of disease. Free radicals and tissue injury. Laboratory Investigation, 47, 412 426.
2. Mates JM, Perez-Gomez C, Nunez de Castro I. (1999) Antioxidant enzymes and human diseases. Clinical Biochemistry, 32, 595 603.
3. Gonzales R, Auclair C, Voisin E, Gautero H, Dhermy D, Boivin P (1984) Superoxide dismutase, catalase, and glutathione peroxidase in red blood cells from patients with malignant disease. Cancer Research, 44, 4137 4139.
4. Abdel-Aziz AF, El-Naggar MM. (1997) Superoxide dismutase activities in serum and white blood cells of patients with some malignancies. Cancer Letters, 113, 61 64.
5. Devi GS, Prasad MH, Saraswathi I, Raghu D, Rao DN, Reddy PP. (2000) Free radicals antioxidant enzymes and lipid peroxidation in different types of leukemias. Clinica Chimica Acta, 293, 53 62.
6. Miyake M, Fuchimoto S, Iwagaki H, Matsubara N, Edamatsu R, Hiramatsu M, Orita K. (1991) Production of hydroxyl radicals by tumour cells varies with cell type as measured by electron spin resonance spectrometry. Research Communications in Chemical Pathology and Pharmacology, 71, 293 307.
7. Comis RL. (1976) DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treatment Reports, 60, 165 176.
8. Atkins MB. (1997) The treatment of metastatic melanoma with chemotherapy and biologics. Current Opinion in Oncology, 9, 205 213.
9. Pyrhonen S, Hahka-Kemppinen M, Muhonen T. (1992) A promising interferon plus four drug chemotherapy regimen for metastasis melanoma. Journal of Clinical Oncology, 10, 1919 1926.
10. Green D, Ahlgren JD, Schein PS, Imbach JI 1981) Nitrosoureas in cancer treatment. In : Serrou B, Schein PS, Imbach JL, eds. Proceeding of international symposium on nitrosoureas in Cancer treatment. Amsterdam : Elsevier, 49.
11. Kristal O, Rassnick KM, Gliatto LM et al. (2004) Hepatotoxicity associated with CCNU (lomustine) chemotherapy in dogs. Journal of Veterinary Internal Medicine, 18, 75 80.
12. Hug H, Strand S, Grambihler A et al. (1997) Reactive oxygen intermediates are involved in the induction of CD95 ligand mRNA expression by cytostatic drugs in hepatoma cells. The Journal of Biological Chemistry, 272, 28191 28193.
13. Kolar GF, Maurer M, Wiedschutte M. (1980) 5-(3-Hydroxymethyl-3-methyl-I- triazen Imidazol-4-carboxamide is a metabolite of 5-(3,3-dimethyl-I-triazeno) imidazole-4-carboxamide (DTIC). Cancer Letters, 10, 235.
14. Mates JM, Sanchez-Jimenez FM. (2000) Role of reactive oxygen species in apoptosis: implications for cancer therapy. The International Journal of Biochemistry & Cell Biology, 32, 157 170.
15. Kalender S, Kalender Y, Ates A, Yel M, Olcay E, Candan S. (2002) Protective role of antioxidant vitamin E and catechin on idarubicin-indused cardiotoxicity in rats. Brazilian Journal of Medical and Biological Research, 34, 1379 1387.
16. Ivanov IT. (1999) Low pH-induced haemolysis of erythrocytes is related to the entry of the acid into cytosole and oxidative stress on cellular membranes. Biochimica et Biophysica Acta, 1415, 349 360.
17. Placer ZA, Cushman LL, Jonson BC. (1966) Estimation of product of lipid peroxidation (Malonyl Dialdehyde) in biochemical systems. Analytical Biochemistry, 16, 359 364.
18. Sun Y, Oberley LW, Li Y. (1988) A simple method for clinical assay of superoxide dismutase. Clinical Chemistry, 34, 497.
19. Beers R, Sizer T. (1974) Spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. The Journal of Biological Chemistry, 195, 133 138.
20. Mahoney JJ, Vreman HJ, Stevenson DK, Van Vessel AL. (1993) Measurements of carboxyhaemoglobin by five spectrophotometers (cooximeters) in comparison with reference methods. Clinical Chemistry, 39, 1693.
21. de Zwart LL, Meerman JHN, Commandeur JNM, Vermeulen NPE. (1999) Biomarkers of free radical damage. Applications in experimental animals and in human. Free Radical Biology & Medicine, 26, 202 226.
22. Isler M, Delibas N, Guclu M, Gultekin F, Sutcu R, Bahceci M, Kosar A. (2002) Superoxid dismutase and glutathione peroxidase in erythrocytes of patients with iron deficiency anemia: effect of different treatment modalities. Croatian Medical Journal, 43, 16.
23. Conklin KA. (2004) Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Cancer Therapies, 3, 294 300.
24. Look MP, Musch E. (1994) Lipid peroxides in the polychemotherapy of cancer patients. Chemotherapy, 40, 8 15.
25. Erhola M, Keilokumpu-Lehtinen P, Metsa-Ketela T, Alanko K, Nieminen MM. (1996) Effects of anthracyclin-based chemotherapy on total plasma antioxidant capacity in small cell lung cancer patients. Free Radical Biology & Medicine, 21, 383 390.
26. Cameron LM, La France RJ, Hemens CM, Vahghman K, Rajaraman R, Ceubb DC, Goddard PM. (1985) Triazene metabolism IV. Derivatives of hydroxymethyl triazenes: potential prodrugs for the active metabolits of the antitumour triazene, DTIC. Anti-Cancer Drug Design, 1, 27 36.
27. Acikgoz S, Bingol F, Offin S, Acikgoz B. (1995) The effect of topical CCNU 1-(2-chloroethyl-3-cyclohexyl)-1-nitrosourea treatment on lipid peroxidation of glial tumors transplanted on rat brian. General Pharmacology, 26, 437 439.
28. Zheleva A, Gadjeva V. (2001) Spin labeled nitrosoureas and triazenes and their nonlabeled clinically used analogues - a comparative study on their physicochemical properties and antimelanomic effects. International Journal of Pharmaceutics, 212, 257 266.
29. Gadjeva V, Kuchukova D, Georgieva R. (2005) Vitamin combination reduce oxidative stress and improve antioxidant status in patients with iron deficiency anaemia. Comparative Clinical Pathology, 15, 43 49.